An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...
More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug ...
Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially ...
In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...
Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination ...